INTRODUCTION {#S1}
============

The development of neuronal circuits requires highly organized connections between discrete neuronal populations and their synaptic targets. The functional consequences of developmental or maladaptive miswiring can be severe. However, despite much interest in this question, there are few cases in vertebrates for which we understand how cell identity drives innervation of the correct target and avoidance of neighboring alternatives ([@R7]).

Facial muscles have a vital role in many complex behaviors. Distributed across the surface of the skull and neck in \~30 pairs, their nuanced activation by branches of the facial motor nerve (cranial nerve VII) underlies respiration and feeding in fish ([@R22]), rhythmic whisking of sensory vibrissae in rodents ([@R28]), and communication through facial expression and spoken language in humans. Loss of facial nerve function because of injury or congenital conditions, such as Moebius syndrome ([@R69]), can lead to socially debilitating facial paralysis. Moreover, facial motor fibers regenerating after nerve injury can innervate incorrect muscles, resulting in facial synkinesis, an inappropriate coordination of facial movement, such as eye closure, triggered by volitional movement of the mouth. Although some cases can be treated by selective chemodenervation ([@R33]), synkinesis remains a significant clinical challenge, and the molecular mechanisms underlying these wiring abnormalities have been little studied.

The muscles of the facial expression are controlled by a population of hindbrain branchiomotor neurons forming the facial motor nucleus, which is structured according to the diversity of its muscle targets ([@R8]). Mammalian facial motor neuron (FMN) cell bodies are organized into distinct subnuclei: medial (M), intermediate (I), dorsolateral (DL), and lateral (L) ([Figures 1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}) ([@R4]; [@R52]; [@R59]). FMN axons form five distinct branches of the facial nerve that innervate separate subsets of muscles. In the mouse, the posterior auricular (PA) and anterior auricular (AA) branches supply the muscles that rotate the ear pinnae ([@R3]), the zygomatic/temporal (Z/T) branch controls the eyelid-closing orbicularis oculi (OO) and extrinsic whisking nasolabialis (NL) muscles ([@R61]), the buccolabial (BL) branch innervates intrinsic muscles of the lip and sensory vibrissae ([@R4]; [@R29]), the marginal mandibular (MM) branch contacts the muscles that move the lower lip ([@R59]), and the cervical (C) branch innervates muscles of the lower jaw ([@R43]) ([Figure 1C](#F1){ref-type="fig"}). This musculature is thought to have evolved from the jaw- and gill slit-opening muscles of primitive aquatic tetrapods, with sometimes extensive remodeling ([@R4]; [@R24]; [@R29]) to support adaptations, such as eyelid-closing muscles in terrestrial animals, somatosensory whisking in mammals, and facial expression in humans ([@R13]; [@R23]). The adaptation of the relative sizes of facial subnuclei to specific evolutionary needs in different mammalian species ([@R18]) suggests they may serve as organizing centers for facial nerve branches, and multiple studies indicate that individual facial branches map to specific subnuclei to varying extents ([@R4]; [@R9]; [@R27]; [@R43]; [@R52]; [@R59]; [@R71]; [@R74]). However, a comprehensive map of facial nucleus musculotopic organization in mouse is lacking.

To identify candidate regulators of the late stages of facial motor map development, we transcriptionally profiled individual facial subnuclei from 16.5 embryonic days (E16.5) mice and found that each subpopulation was defined by a unique combinatorial gene-expression program. The molecular identity of a given subnucleus correlates with neuronal birth date, whereas spatial aggregation occurs through stereotyped patterns of migration toward, and within, the developing facial nucleus. We studied in more detail the role of the Ets transcription factor ETV1---already shown to label a subset of FMNs ([@R1])---in the development of FMNs of the DL subnucleus and the motor pools innervating the OO and NL muscles. ETV1 is required for correct positioning of each DL motor pool and for complete innervation of its target muscle. Moreover, it activates downstream expression of a series of candidate effectors. As a striking functional correlate of this role, we show that loss of *Etv1* generates synkinesis between eyelid and nasal muscles. We, therefore, propose that ETV1 acts as a regulator of late aspects of facial motor-neuron development, driving both the growth of their axons and the segregation of their cell bodies in distinct subnuclei, required for non-overlapping innervation of their targets.

RESULTS {#S2}
=======

Somatotopic Projections of Facial Subnuclei in Mouse {#S3}
----------------------------------------------------

We used retrograde labeling in post-natal day (P)-zero mice to map the subnuclei of origin for each facial nerve branch ([Figure 1C](#F1){ref-type="fig"}). We observed that the PA and AA branches originated exclusively in the ventral and dorsal regions of the M subnucleus, respectively ([Figures 1D](#F1){ref-type="fig"}, [1E](#F1){ref-type="fig"}, [S1A](#SD1){ref-type="supplementary-material"}, and [S1B](#SD1){ref-type="supplementary-material"}). The MM branch arose solely from the I subnucleus ([Figures 1F](#F1){ref-type="fig"} and [S1C](#SD1){ref-type="supplementary-material"}). The Z/T branch was formed by FMNs of the DL subnucleus as well as a few in the dorsal M subnucleus ([Figures 1G](#F1){ref-type="fig"} and [S1D](#SD1){ref-type="supplementary-material"}) ([@R59]). Lastly, the buccolabial branch arose primarily from the L subnucleus, with a smaller contribution from the I subnucleus ([Figures 1H](#F1){ref-type="fig"}, [1I](#F1){ref-type="fig"}, [S1E](#SD1){ref-type="supplementary-material"}, and [S1F](#SD1){ref-type="supplementary-material"}). These observations, summarized in [Figure 1J](#F1){ref-type="fig"}, provide a firm basis on which to link FMN identity to somatotopic innervation of target muscles.

Transcriptional Profiling Identifies Markers of Developing Facial Motor Subnuclei and Motor Pools {#S4}
-------------------------------------------------------------------------------------------------

To identify potential molecular correlates of FMN cell-body position, we used laser-capture microdissection to isolate M, I, DL, and L subnuclei from mouse hindbrain cryosections at embryonic day E16.5 ([Figures 1K](#F1){ref-type="fig"} and [1L](#F1){ref-type="fig"}), a time point at which facial subnuclei can be distinguished anatomically ([Figure 1B'](#F1){ref-type="fig"}) but may still retain expression of genes regulating FMN migration and target innervation ([@R63]) ([Figures 3A](#F3){ref-type="fig"}--[3F](#F3){ref-type="fig"} and [6A](#F6){ref-type="fig"}). Microarray analysis of the individual facial motor subnuclei revealed a striking level of molecular heterogeneity among the four subpopulations, with 58--172 transcripts showing \>4-fold enrichment in pairwise comparisons among these populations ([Figure 1M](#F1){ref-type="fig"}; [Table S1](#SD3){ref-type="supplementary-material"}). We used *in situ* hybridization (ISH) to confirm the microarray data and map the markers with increased resolution ([Figures 2](#F2){ref-type="fig"} and [S1G](#SD1){ref-type="supplementary-material"}--[S1P](#SD1){ref-type="supplementary-material"}). We identified three groups of expression patterns of graded selectivity ([Figures 2A](#F2){ref-type="fig"}--[2D](#F2){ref-type="fig"}): class 3 genes, expressed in three or more FMN subnuclei; class 2 genes, which marked two different FMN subnuclei; and class 1 genes, whose expression was restricted to a single FMN subnucleus. We classified the last group into two subgroups. Class 1A genes labeled entire subnuclei ([Figure 2A](#F2){ref-type="fig"}), suggesting a potential role determining subnucleus identity. In accordance with that, several class 1A genes are transcription factors whose expression is most pronounced in the M (*Klf5*, *Prickle1*), I (*FoxP1*), and L (*Nr2f2*, *Trps1*) or DL (*Etv1*) subnucleus. Class 1B genes showed even more restricted expression, limited to a subset of neurons within a single subnucleus only ([Figure 2B](#F2){ref-type="fig"}), raising the possibility that they might be markers for specific facial motor pools. To test that idea, we injected the two muscles controlled by the DL facial subnucleus, the OO and NL, with Alexa 488- and Alexa 597-conjugated cholera toxin B subunit (A488CTB, A597CTB), respectively. Retrogradely labeled OO and NL FMNs formed two distinct groups within the *Etv1*^*ON*^ DL subnucleus, partially segregated along the mediolateral axis ([Figure 2E](#F2){ref-type="fig"}). Single cholera toxin B (CTB) injections, followed by ISH, showed that the class 1B DL marker *Cntn3* defined the OO motor pool, whereas *Sostdc1* specifically marked a subset of the NL motor-pool neurons. Within the DL, class 2 marker *Gria3* and class 3 marker *Alcam* were also restricted to the NL pool ([Figures 2F](#F2){ref-type="fig"}, [2G](#F2){ref-type="fig"}, and [7E](#F7){ref-type="fig"}). Therefore, similar to their spinal counterparts ([@R10]), FMNs are organized into distinct motor pools defined by combinatorial expression of marker genes ([Figure 2H](#F2){ref-type="fig"}).

ETV1 and FOXP1 Predefine Specific Subnuclei during Ventral Migration and Segregation of FMNs {#S5}
--------------------------------------------------------------------------------------------

We next studied the developmental steps that lead to precise segregation of FMN subsets. As visualized by whole-mount ISH for *Isl1* between E11.5 and E15.5 ([Figure 3A](#F3){ref-type="fig"}), the developmental migration of FMNs encompasses three main phases: caudal migration from rhombomere (r) 4 to r6, ventral (radial) migration within r6 to form the facial nucleus ([@R20]; [@R56]), and segregation within the facial nucleus to form the subnuclei. Differential gene expression within the caudal migratory stream has been reported ([@R63]), but the stage at which the distinct, terminal identities of FMNs are determined, and how they segregate on the way to their final location, has not, to our knowledge, been studied. We used *FoxP1* and *Etv1* as markers of specific FMN populations to address those questions, applying ISH on intact brainstems to visualize their entire expression pattern at once. Neither gene was expressed in FMNs during the initial caudal phase of migration ([Figures 3B](#F3){ref-type="fig"} and [3C](#F3){ref-type="fig"}). A subset of *FoxP1*-expressing (*FoxP1*^*ON*^) FMNs was first detected at E12.5 during ventral migration and by E15.5 had congregated into an anatomically distinct I subnucleus ([Figure 3B](#F3){ref-type="fig"}). *Etv1* expression was not apparent until E13.5, when it also marked a scattered subpopulation of FMNs ([Figure 3C](#F3){ref-type="fig"}). By E15.5, most *Etv1*^*ON*^ FMNs had coalesced into a distinct DL subnucleus ([Figure 3C](#F3){ref-type="fig"}, arrows) with some *Etv1*^*ON*^ FMNs forming a sparse, more-M band of cells that occupy dorsal positions in the M and I subnuclei ([Figures 2A](#F2){ref-type="fig"} and arrowheads in [3C](#F3){ref-type="fig"}). Expression of the class 3 marker *Nrp2* and the class 2 marker *Zeb2* also displayed subpopulation specificity within the migratory stream at E13.5, which presaged the distribution of expression observed when FMNs reached their final somatotopic positions at E16 ([Figures S1G](#SD1){ref-type="supplementary-material"}--[S1J](#SD1){ref-type="supplementary-material"}).

We used immunolabeling on E11.5--E15.5 sections to determine how the ETV1^ON^ and FOXP1^ON^ populations emerged and segregated ([Figures 3D](#F3){ref-type="fig"}--[3F](#F3){ref-type="fig"}). No FMNs co-expressed ETV1 and FOXP1, and at no point did we observe intermingling ([Figure 3F](#F3){ref-type="fig"}). Moreover, each group projected only to its cognate target; 94.0 ± 2.5% of FMNs labeled by Z/T branch retrograde tracing at P1 were ETV1-immunopositive and located within the DL subnucleus ([Figure S2A](#SD1){ref-type="supplementary-material"}; n = 3 control mice, 143 FMNs). By early postnatal stages, FOXP1 expression expanded to FMNs beyond the I subnucleus ([Figure S2B](#SD1){ref-type="supplementary-material"}), but FMNs labeled from the MM branch remained, nonetheless, positioned as the FOXP1^ON^ I population observed at E15.5--E16.5 ([Figures 2A](#F2){ref-type="fig"} and [3F](#F3){ref-type="fig"}). To determine whether migration itself is required for the onset of expression of each marker, we analyzed cyclin-dependent kinase 5 (*Cdk5*) knockout mice, in which FMNs are born normally but fail to migrate caudally from r4 ([@R51]). In E16.5 *Cdk5* mutants, the ETV1^ON^ DL and FOXP1^ON^ I FMNs did not form subnuclei and, instead, were dispersed within the dorsal and ventral compartments, respectively, of the r4 FMN population ([Figures 3G](#F3){ref-type="fig"}--[3L](#F3){ref-type="fig"}), but nevertheless, the facial nerve exited the skull and formed branches ([Figures S2F](#SD1){ref-type="supplementary-material"}--[S2H](#SD1){ref-type="supplementary-material"}). Thus, the migration of FMNs from r4 to r6 does not appear to be required for expression of *Etv1* and *FoxP1* in FMN subpopulations at later stages.

To determine the relation of FMN birth date to terminal identity, we labeled mouse embryos in utero at E9.5, E11, and E12 with the thymidine analog 5-ethynyl-2′-deoxyuridine (EdU). The later the time of injection, the more lateral were the FMN populations labeled at E14.5 ([Figures 4A](#F4){ref-type="fig"}--[4F](#F4){ref-type="fig"}). FOXP1^ON^ I FMNs were born early, between E9.5 and E11, whereas most ETV1^ON^ DL FMNs were born later (E11--E12; [Figure 4G](#F4){ref-type="fig"}).

Although it is possible that the shifts in ETV1 and FOXP1 expression reflect temporal changes of gene regulation sweeping through the FMN population, the position of FOXP1^ON^ FMNs ahead of the ETV1^ON^ population in the migratory stream at E13.5 ([Figure 3F](#F3){ref-type="fig"}, third column) suggests that the facial nucleus is built from waves of FMNs with successively later birth dates. In this model, later-born FMNs occupy progressively more-lateral settling positions, consistent with recent analysis of zebrafish FMN development ([@R44]).

The final stage of migration is segregation within the developing facial nucleus. Because the trailing axon deposited by migrating FMNs provides a record of their migratory path ([@R61]), we used immunostaining for the axon initial segment (AIS) marker ANKYRIN-G to assess proximal axon orientation in facial subnuclei in neonatal control mice ([Figures 4H](#F4){ref-type="fig"}--[4K](#F4){ref-type="fig"}). For a series of neurons in each subnucleus, we plotted the deduced direction of recent migration as a vector and quantified their orientations ([Figure 4L](#F4){ref-type="fig"}). M and I subnucleus axonal vectors displayed a radial distribution, indicating that these structures formed from the clustering of initially dispersed subpopulations, whereas mediolateral and dorsoventral biases were observed for DL and L subnuclei, respectively, implying that they migrate to their final positions via single, but distinct, migratory paths.

Our findings, thus far, indicate that subnucleus-specific gene-expression patterns are activated during migration of FMNs toward the site of the presumptive facial nucleus. Initially, FMNs settle along the mediolateral axis as a function of birth date. Nevertheless, the congregation of these FMNs into coherent subnuclei requires a fine-grained, secondary migration, which leads to precise sorting within the nascent nucleus ([Figures 4H](#F4){ref-type="fig"}--[4M](#F4){ref-type="fig"}). However, it remained to be determined whether any of the class 1 genes used as markers have a functional role in that migration.

*Etv1* Assigns Transcriptional and Positional Identity to DL FMNs {#S6}
-----------------------------------------------------------------

Because *Etv1* expression appears in DL FMNs during the final stages of their migration to somatotopic positions and target-muscle selection by the corresponding axons, we focused our attention on its potential role in orchestrating those processes. In *Etv1*^*nls-LacZ/nls-LacZ*^ (referred to here as *Etv*^*nlz/nlz*^) mutants ([@R2]), an anatomically distinct DL subnucleus failed to form and was, instead, replaced by a large cleft devoid of FMNs flanked by apparently enlarged I and L subnuclei ([Figures 5B](#F5){ref-type="fig"} and [5D](#F5){ref-type="fig"}; arrows). We attempted to visualize the positions of DL FMNs using the β-galactosidase (β-gal) reporter encoded by the *Etv1*^*nlz*^ mutant allele. In heterozygous *Etv1*^*nlz/+*^ facial nuclei at E16.5, β-gal expression was coincident with ETV1 immunoreactivity ([Figure S3A](#SD1){ref-type="supplementary-material"}). However, no β-gal^ON^ FMNs were detected in *Etv1*^*nlz/nlz*^ knockouts ([Figure 5D](#F5){ref-type="fig"}), whereas β-gal expression in ETV1^ON^ dorsal root ganglion and inferior olive neurons was maintained ([Figures S3B](#SD1){ref-type="supplementary-material"}--[S3E](#SD1){ref-type="supplementary-material"}). Therefore, either DL FMNs are lost in the absence of *Etv1* or ETV1 is required to maintain its own transcription through an autoregulatory module.

We found no overall change in the total number of FMNs ([Figures S4A](#SD1){ref-type="supplementary-material"}--[S4C](#SD1){ref-type="supplementary-material"}) and no increase in programmed cell death as determined by caspase-3 cleavage at E14.5 ([Figures 5E](#F5){ref-type="fig"}--[5G](#F5){ref-type="fig"}) in *Etv1* mutants, indicating that DL FMNs are not lost. Furthermore, retrograde labeling from the Z/T nerve at P2 ([Figures 5H](#F5){ref-type="fig"} and [5I](#F5){ref-type="fig"}) marked similar numbers of FMNs in controls and *Etv1* mutants ([Figure 5J](#F5){ref-type="fig"}). However, in mutants, some of these neurons occupied ectopic positions deep within the L subnucleus ([Figures 5I](#F5){ref-type="fig"}, arrows, and [5K](#F5){ref-type="fig"}). They also showed striking modifications in gene expression patterns: the OO motor-pool marker *Contactin-3* and the NL motor-pool marker *Sostdc1* were barely detectable at E16.5 and were excluded from OO and NL FMNs in *Etv1-*mutant neonatal mice ([Figures 5N](#F5){ref-type="fig"}, [5O](#F5){ref-type="fig"}, [S4H](#SD1){ref-type="supplementary-material"}, and [S4I](#SD1){ref-type="supplementary-material"}). Similarly, the class 2 NL motor-pool markers *C1ql1* and *Gria3* and the class 3 DL marker *Ldb2* were absent from the DL and L regions of the mutant facial nucleus but were maintained as expected in the other subnuclei ([Figures 5P](#F5){ref-type="fig"}--[5R](#F5){ref-type="fig"}). By contrast, the class 3 DL marker *Alcam* was detected in ectopic positions in the L subnucleus of the *Etv1* mutants, where it may label mislocalized DL FMNs in an ETV1-independent manner ([Figure 5S](#F5){ref-type="fig"}). The persistence of DL FMNs in mice lacking *Etv1* and the requirement of ETV1 for the expression of a battery of secreted molecules and transcription factors---including itself and with the exception of *Alcam*---underscore the essential role ETV1 has in establishing DL FMNs mature transcriptional identity.

Etv1 Controls the Innervation of Select Facial Muscles {#S7}
------------------------------------------------------

As FMNs migrate, their axons are simultaneously projecting toward their target muscle anlagen. The facial nerve emerges from the developing skull by E11.5 and, over the subsequent 2 days, facial nerve branches become apparent. At E15.5, the pattern of facial nerve-branch formation is established, and the innervation of the facial musculature is underway ([Figure 6A](#F6){ref-type="fig"}; [@R15]). We asked whether ETV1 has a role in the innervation of DL target muscles. The overall trajectories of the Z/T and other facial nerve branches were unchanged in *Etv1* mutants at E13.5 ([Figures 6B](#F6){ref-type="fig"} and [6C](#F6){ref-type="fig"}). By E15.5, Z/T axons of control mice have grown dorsally over the eye to the nasal side of the eyelid, where a subset of DL axons defasciculate to innervate the OO muscle and the remainder continue to grow into the NL and the smaller nasolabialis superficialis muscle ([Figure 6D](#F6){ref-type="fig"}) ([@R26]). Strikingly, in *Etv1* mutants, the extent of NL innervation by the Z/T was reduced, reaching 50% loss at E16.5 ([Figures 6E](#F6){ref-type="fig"}, [6H](#F6){ref-type="fig"}, and [6J](#F6){ref-type="fig"}). The few Z/T fibers that did enter the NL muscle were restricted to its dorsal half, leaving space for ectopic invasion by neighboring buccolabial axons ([Figures 6E](#F6){ref-type="fig"}, [6H](#F6){ref-type="fig"}, arrows, and [6L](#F6){ref-type="fig"}, arrowhead). Innervation of the OO muscles in *Etv1* mutants was reduced by \~85% compared with controls ([Figures 6G](#F6){ref-type="fig"}, [6I](#F6){ref-type="fig"}, and [6J](#F6){ref-type="fig"}). The trajectory of the Z/T branch and its caliber at a point proximal to the OO muscle were unchanged in *Etv1* mutants ([Figures 6B](#F6){ref-type="fig"}, [6C](#F6){ref-type="fig"}, arrows, [6F](#F6){ref-type="fig"}, and [6H](#F6){ref-type="fig"}, arrowheads), indicating that the failure to completely innervate the OO and NL is a distal defect. Moreover, innervation of the ML muscle, an extrinsic whisking muscle lying deep to the NL---and innervated by *Etv1*^*OFF*^ L subnucleus FMNs ([Figure 2B](#F2){ref-type="fig"}) ([@R14]; [@R28])---was unchanged ([Figure 6J](#F6){ref-type="fig"}). *Etv1* expression was largely absent from the facial periphery and sensory ganglia as FMN axons grow toward, and invade, their muscle targets ([Figure S5](#SD1){ref-type="supplementary-material"}), consistent with ETV1 having a selective and likely cell-autonomous role in driving the full innervation of the DL target muscles.

Loss of Etv1 Function Leads to Facial Synkinesis {#S8}
------------------------------------------------

Although the innervation of OO and NL muscles in *Etv1* mutants is reduced, each muscle nonetheless still appears to receive a detectable level of motor input. We asked to what degree selective projections by each pool onto their appropriate muscle target were maintained in the absence of *Etv1*, using retrograde labeling in conjunction with ISH for the ETV1-independent NL motor-pool marker *Alcam*. In control mice, we observed the expected close correlation between *Alcam* expression and NL muscle innervation ([Figures 7A](#F7){ref-type="fig"} and [7E](#F7){ref-type="fig"}), whereas almost no *Alcam* was detected in the OO motor pool ([Figures 7B](#F7){ref-type="fig"} and [7E](#F7){ref-type="fig"}). By contrast, in *Etv1* mutants, \~60% of OO-innervating FMNs expressed *Alcam*, whereas a similar proportion of NL-innervating FMNs were *Alcam*-negative as expected for OO FMNs ([Figures 7C](#F7){ref-type="fig"}--[7E](#F7){ref-type="fig"}). Thus, the specificity of axonal projection is severely eroded in *Etv1* mutants, in which a large fraction of motor inputs onto the OO muscle originate from FMNs that display the molecular identity of the NL motor pool and vice versa.

A potential behavioral correlate for these axon-targeting errors came from the observation that the eyes of *Etv1* mutants remained completely or partially closed at P18 ([Figures 7F](#F7){ref-type="fig"} and [7H](#F7){ref-type="fig"}). We found an 80% reduction in eye opening in *Etv1* mutants compared with control mice ([Figure 7J](#F7){ref-type="fig"}). Despite that, the overall structure of mutant eyelids---including the separation of the upper and lower lids into distinct structures---matched that of controls ([Figures 7H](#F7){ref-type="fig"} and [7I](#F7){ref-type="fig"}).

Abnormal eyelid closure could result from tonic activation of the OO muscle, as seen in the human disorder of blepharospasm, or from impaired activation of the levator palpebrae superioris (LPS) muscle, the OO antagonist that opens the eye ([@R6]). To directly test the former hypothesis, we unilaterally severed the Z/T branch to denervate the OO. In control mice, this intervention did not affect the palpebral closure index (PCI; palpebral fissure height/width) ([Figures 7F](#F7){ref-type="fig"}, [7G](#F7){ref-type="fig"}, and [7J](#F7){ref-type="fig"}). In striking contrast, OO denervation in *Etv1* mutants led to a \>4-fold improvement in palpebral closure index ([Figures 7H](#F7){ref-type="fig"}--[7J](#F7){ref-type="fig"}), likely reflecting preserved tonic activation of the LPS muscle relieved of aberrant OO antagonism.

To determine directly whether the OO muscle had been aberrantly recruited into the whisking circuit in *Etv1* mutants, we recorded electromyographic (EMG) activity from the OO and NL muscles in awake mice at P19 ([@R53]). In control animals, infrequent (\~0.01 Hz), single bursts of OO activity, coincident with eyelid blinks, were detected ([Figure 7K](#F7){ref-type="fig"}, asterisk) ([@R5]), with no corresponding activation of the NL. Conversely, OO activation during whisking bouts was very rare (1/99 epochs; [Figure 7L](#F7){ref-type="fig"}, bottom panel; n = 8 mice). In *Etv1* mutants, despite the reduced motor input, the frequency of NL activation during whisking was similar to that of controls ([Figure 7M](#F7){ref-type="fig"}, bottom panel). In striking contrast, *Etv1* mutant OO activity was often modulated during epochs of whisking, in phase with the high-frequency (\~8 Hz) NL activation (28/39 epochs, 72%, n = 6 mice; [Figure 7M](#F7){ref-type="fig"}, top panel). The high-frequency motor drive ectopically directed onto the OO muscle in *Etv1* mutants is, therefore, likely to originate from the NL motor pool ([Figures 7N](#F7){ref-type="fig"} and [S7](#SD1){ref-type="supplementary-material"}).

These observations, together with misprojection by OO and NL motor pools, support a model in which aberrant targeting of NL motor axons onto the OO muscle causes it to contract improperly at the consistently rhythmic firing rates of whisking (8--15 Hz) and respiration (\~3 Hz) ([@R28]; [@R47]), leading to an eyelid-closure phenotype reminiscent of synkinesis in human patients.

DISCUSSION {#S9}
==========

The coordinated activation of facial muscles---which underlies multiple essential behaviors---requires somatotopic connections between FMNs and specific muscle targets with diverse functions. We report extensive molecular heterogeneity among FMNs, which can be mapped to the level of single facial motor pools. We used marker genes to show that birth date, together with stereotyped patterns of caudal migration and cell sorting, helps determine the segregation of FMNs into subnuclei with discrete peripheral-projection areas. One such marker, the Ets transcription factor ETV1, acts as an essential regulator of the specific molecular and positional identity of DL FMNs, as well as the innervation of their muscle targets. In its absence, motor pools that normally project to neighboring muscles with no overlap show randomization of their projections, resulting in aberrant patterns of muscle activation reminiscent of the human condition of facial synkinesis.

Molecular Diversity of Facial Subnuclei and Motor Pools {#S10}
-------------------------------------------------------

The patterns of gene expression we found to define FMN subpopulations fell into four main classes. Class 1A genes, such as transcription factors *Klf5*, *FoxP1*, and *Etv1*, are expressed by all neurons in a single subnucleus, suggesting that they have a major role in coordinating the different projections within the corresponding nerve branch ([Figures 1J](#F1){ref-type="fig"} and [2A](#F2){ref-type="fig"}). In this study, we have begun to characterize the role of *Etv1*, but other class 1A genes may similarly assign facial motor subnucleus identity. Class 1B genes that label subpopulations within a single subnucleus include markers for specific facial motor pools: *Cntn3*, expressed only in OO FMNs, and *Sostdc1*, restricted to a subpopulation of NL FMNs. Many class 2 and class 3 genes also labeled small clusters of FMNs, including *Alcam* and *Gria3*, which mark the NL motor pool within the DL subnucleus, suggesting that, like their spinal counterparts ([@R34]), each FMN pool has a unique combinatorial, transcriptional identity.

Many of the genes identified by our screen encode cell-surface and secreted molecules that have the potential to guide migration of FMN cell bodies and growth cones ([Figure 2](#F2){ref-type="fig"}). For example, the complementary expression of *EfnA5* and of multiple EphA receptors by M and L facial nuclei ([Figures 2B](#F2){ref-type="fig"} and [2D](#F2){ref-type="fig"}) would allow bidirectional, repulsive signaling to cluster the corresponding axon fibers within the common nerve in a manner that anticipates their branch-specific ramifications ([@R38]) as found in the optic nerve ([@R66]). At later stages, highly restricted expression of *EphA3* in a ventral group of L FMNs ([Figure 2B](#F2){ref-type="fig"}) could sensitize those fibers to *Efna5-*repellent ligands expressed in the developing mystacial pad ([@R72]), thereby attenuating their dorsal growth and guiding them to their ventral target muscles. This would be reminiscent of topographic maps in the visual system in which Eph/ephrin signaling has a central role ([@R70]).

Similarities and Differences Compared with Spinal Motor Neuron Development {#S11}
--------------------------------------------------------------------------

In the ventral spinal cord, motor neurons (MNs) congregate into discrete clusters, termed motor pools, each of which innervates a single muscle ([@R55]; [@R61]). A comparable organization has been proposed in the simian facial nucleus ([@R31]). The molecular characterization we report demonstrates the existence of such FMN pools in the mouse ([Figure 2F](#F2){ref-type="fig"}). At limb levels, spinal motor pools are grouped into columels with fixed spatial coordinates ([@R67]), which may bear similarities to facial subnuclei. Late stages of spinal MN differentiation are controlled by ETV5 in specific brachial motor pools, whereas ETV1 controls targeting of proprioceptive circuits onto skeletal muscle ([@R2]; [@R25]; [@R42]). ETV1 acts at relatively earlier stages in the facial nucleus than it does in the spinal cord, guiding DL subnucleus positioning and projection in a manner reminiscent to that of ETV5 in the brachial spinal cord ([@R42]). *Etv1* expression is also absent from the trigeminal ganglia that supply sensory input to facial tissues, indicating that its role in spinal proprioceptive circuit formation is not recapitulated in the facial motor system ([Figures S5I](#SD1){ref-type="supplementary-material"} and [S5J](#SD1){ref-type="supplementary-material"}). However, although the underlying mechanisms of its action may differ, ETV1 is important in establishing motor circuits at both hindbrain and spinal levels. Therefore, there are strong parallels, despite clear differences, between branchiomotor and somatic motor neurons in the mechanisms controlling somatotopic innervation of their target muscles.

Evolutionary Influences on FMN Migration, Subnucleus Formation, and Somatotopy {#S12}
------------------------------------------------------------------------------

The developmental logic of the caudal migration of FMNs that occurs in embryonic mammals and fish, but not in embryonic birds and reptiles, has eluded explanation ([@R21]). Caudal migration may bring the FMNs that mediate respiratory behaviors---gill opening in fish and airway patency in mammals ([@R22]; [@R48])---in closer proximity to caudal hindbrain respiratory centers ([@R44]). However, FMNs in fish and mammals do control facial motor behaviors beyond respiration ([@R13]; [@R22]; [@R65]). Cell migration could also provide the time and space needed for those cells to "sample" the repertoires of cell-surface receptors displayed by their neighbors and aggregate into somatotopic subnuclei, based on shared receptor expression, a mechanism used in the assembly of spinal motor pools ([@R11]). The failure of ETV1^ON^ DL and FOXP1^ON^ I FMNs to cluster into subnuclei when caudal migration is interrupted in *Cdk5* mutants is consistent with that model, although the effects of CDK5 loss are likely pleiotropic and could cause an overall, non-specific impairment of cell migratory behavior.

The mediolateral progression we report in the settling of FMN in the developing nucleus may reflect the evolution of tetrapod facial motor specialization ([Figure S6](#SD1){ref-type="supplementary-material"}). The jaw-opening muscles of primitive aquatic tetrapods are thought to have given rise to mammalian proximal ear, jaw, and neck muscles innervated by the M and I FMNs ([@R37]; [@R49]), whereas muscles that open the gill slits are ancestral to more distal mammalian eyelid, nose, and lip muscles innervated by DL and L FMNs ([@R13]). Early born mammalian M and I subnuclei may, therefore, represent the vestige of an ancient-core facial nucleus that supported aquatic feeding and respiratory behaviors. DL and L subnuclei would have subsequently arisen to innervate new facial muscles, mediating behaviors essential for terrestrial life (e.g., eyelid closure and somatosensory whisking) by deploying complex, combinatorial, transcriptional, and axon-targeting schemes to accurately innervate increasingly complex anterior facial musculature ([Figure S6C](#SD1){ref-type="supplementary-material"}) ([@R23]; [@R62]).

ETV1 as a Determinant of DL FMN Fate {#S13}
------------------------------------

Facial muscles with widely divergent firing patterns lie in close apposition ([@R13]). Therefore, even a low level of miswiring could cause debilitating synkinesis among these small, but functionally vital, muscles. ETV1 is a likely mediator of the gene-expression program required to prevent inaccuracies in DL axon targeting. Surprisingly, we found that the loss of ETV1 did not lead to the constitutively open eyelid associated with OO paresis but, instead, to a closed-eye phenotype caused by tonic OO muscle contraction ([Figure 7](#F7){ref-type="fig"}), a condition that was relieved by OO denervation. We demonstrate that there is near-randomization of the synaptic targeting of DL motor axons in the absence of ETV1 ([Figure 7](#F7){ref-type="fig"}) and, as a result, synkinetic activation of the OO coordinated with high-frequency NL contraction during bouts of active whisking. Together, these observations suggest that a single determinant of facial subnucleus identity may establish specificity even *within* the groups of neurons whose phenotypes it defines. How may that be controlled? The ectopic activation of OO-innervating FMNs during whisking in *Etv1* mutants may reflect the loss of pool specific factors that allow whisking afferents to distinguish NL and OO FMNs. It may also be a secondary effect of the displacement of some OO FMNs into the L subnucleus territory normally occupied by FMNs that innervate intrinsic vibrissal muscles ([Figures 5I](#F5){ref-type="fig"}, [5K](#F5){ref-type="fig"}, [7D](#F7){ref-type="fig"}, and [S4E](#SD1){ref-type="supplementary-material"}) ([@R36]; [@R68]). In the spinal cord, MN soma position determines afferent input ([@R67]), and displaced OO neurons might be the target for inappropriate innervation from nearby relays of cortical whisking command ([@R68]).

"Terminal selector" transcription factors determine the anatomic and functional properties of mature neuronal subpopulations by regulating "terminal effector" genes that, in turn, define the cytoarchitectural, electro-physiological, and functional properties of postmitotic, mature neurons ([@R30]; [@R60]; [@R64]). The expression of terminal selectors is sustained over time by feed-forward, autoregulatory loops, through which, they activate their own promoters ([@R12]). *Etv1* displays several hallmarks of a candidate terminal selector for DL FMN identity, including subpopulation-specific expression in adult stages ([Figures S2C](#SD1){ref-type="supplementary-material"} and [S2E](#SD1){ref-type="supplementary-material"}), transcriptional autoregulation ([Figures 5C](#F5){ref-type="fig"} and [5D](#F5){ref-type="fig"}), and regulation of a battery of candidate effectors ([Figures 5N](#F5){ref-type="fig"}--[5R](#F5){ref-type="fig"}). Recent chromatin immunoprecipitation sequencing (ChIP-seq) analyses performed on non-neuronal cell types are indeed consistent with direct *Etv1* autoregulation and ETV1 binding to possible regulatory regions of the candidate effectors *Sostdc1* and *Ldb2* ([@R75]). In a striking parallel, ETV1 also serves as a terminal selector in mouse olfactory bulb neurons, where it regulates dopaminergic gene expression ([@R17]). It remains to be determined whether the low level of ETV1 maintained in postnatal DL FMNs is required for DL functional identity at adult stages and, if so, whether any of the ETV1-dependent class 1 DL subnucleus markers identified in our screen function postnatally as terminal effectors.

The gene regulatory mechanisms that lie upstream of the initial expression of class 1A genes such as *Etv1* remain to be defined. In the spinal cord, motor pool-specific expression of *Etv1* and *Etv5* depends on signals from the periphery ([@R25]; [@R42]; [@R73]). In a striking parallel, LIFRβ signaling is required for the formation of a single DL subnucleus by ETV1-expressing FMNs ([@R1]). The effectors that guide the architectural and physiological characteristics of DL FMNs also remain to be identified. Our screen identified several candidates ([Figures 5N](#F5){ref-type="fig"}--[5R](#F5){ref-type="fig"}). Paralogs of the OO motor pool marker *Cntn3* function in cell adhesion and axon guidance ([@R45]), and CNTN3 would be positioned to detect eyelid-specific guidance ligands. The NL pool marker and glutamate receptor *Gria3* may function to support the physiological demand of high-frequency whisking and respiratory activation of these FMNs. The Wnt signaling antagonist and NL pool marker *Sostdc1* could modulate NL motor axon response to peripheral Wnt signals expressed in the region of the nasal eyelid choice point ([@R40]; [@R41]).

In conclusion, our findings begin to assign logic to a remarkable molecular diversity of developing facial motor-neuron subpopulations. We demonstrate that ETV1 has a critical role in defining the final transcriptional and functional identity of dorsolateral facial motor neurons. The loss of facial somatotopy and coordinated motor control in the absence of ETV1 underscores how critically dependent motor function is on the neuronal positioning and axon targeting established during development. In the future, it may be possible to manipulate those same pathways for the treatment of facial nerve injury and disease.

STAR★METHODS {#S14}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S15}
---------------------------------------

Requests for further information should be directed to Alan P. Tenney (<alantenney@alumni.harvard.edu>). Reagents were obtained from commercial sources or donating laboratories as indicated. This study did not generate new unique reagents.

EXPERIMENTAL MODELS AND SUBJECT DETAILS {#S16}
---------------------------------------

The following previously published mouse strains were used in this study: *Etv1* (former *Er81*)^*nlslacZ*^ (RRID: MGI:3621019) ([@R2]), *Thy1::YFP* Line 16 (RRID: IMSR_JAX:003709) ([@R16]), *Cdk5*^−/−^(RRID: IMSR_JAX:003536) ([@R51]), *Isl1*^*MN*^*::GFP* (RRID: IMSR_JAX:017952) ([@R39]). Male and female mice were both used depending on availability and were maintained in microisolator cages. All comparisons were made between experimental mice and littermate controls. For timed developmental studies, detection of a vaginal plug at 9AM was considered embryonic day 0.5. All experiments and procedures were performed according to NIH guidelines and approved by the Institutional Animal Care and Use Committee of Columbia University, NIH, or Boston Children's Hospital.

METHOD DETAILS {#S17}
--------------

### Retrograde tracing and axotomy {#S18}

In order to label specific facial nerve branches with a retrograde tracer, facial motor nerve and intramuscular branches of cryoanesthetized neonatal *Thy1::YFP* mice were visualized on an Olympus dissecting fluorescent microscope, severed with fine forceps or a tungsten needle, respectively, and 0.3 μl of lysine fixable tetramethylrhodamine-dextran (Rh-Dx; 10,000MW, Thermofisher) was applied to the proximal nerve stumps. Individual NL and OO motor pools were also labeled singly and doubly through intramuscular injection of Alexa Fluor-conjugated choleratoxin B (Alexa-CTB). Mice were perfused with 4% paraformaldehyde/0.1 M phosphate buffer (4%PFA/PB) 24 h post injection, hindbrains post-fixed in 4%PFA/PB overnight, cryoprotected in 30% sucrose/PB, and embedded in optimal cutting temperature compound (OCT, Tissue-Tek) for storage and cryosectioning. For behavioral studies, the Z/T facial nerve branches of P19 *Thy1::YFP* mice were visualized and severed as described above under isofluorane anesthesia.

### Laser Capture Microdissection and Microarray analysis {#S19}

12 μm-thick cryosections were collected from E16.5 C57/Bl6 mouse hindbrains fresh frozen in OCT and mounted on RNase-free, PEN-foil covered glass slides (Zeiss), followed by dehydration and staining with 1% Cresyl Violet prior to LCM using PALM Micro-beam system (Zeiss). Every 5^th^ section was collected on a glass reference slide and stained with guinea pig anti-ISL1/2 primary (gift from Tom Jessell, Columbia University) and horse radish peroxidase (HRP)-conjugated anti-guinea pig secondary (Sigma-Aldrich) antibodies. Antibody binding was visualized with a 3,3′-Diaminobenzidine tetrahydrochloride (DAB) chromogenic HRP stain (Sigma-Aldrich) to confirm the range of sections containing FMNs. M, I, DL and L subnuclei from sets of 3 hindbrains were collected directly into lysis buffer, pooled, processed for RNA extraction (Absolutely RNA, NanoPrep kit, Stratagene, La Jolla, CA). RNA integrity number (RIN) was assessed on the Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). Approximately 1.5ng of purified RNA was amplified in the WT-Ovation Pico RNA Amplification System (Nugen) and hybridized to Affymetrix GeneChip Mouse Genome 430 2.0 Arrays ([@R35]).

### *In situ* Hybridization (ISH) {#S20}

ISH protocol was followed as previously described on cryosections ([@R58]) and whole mount embryonic hindbrains ([@R19]) at the indicated developmental stages. Riboprobe templates were generated from cDNA clones or through PCR amplification using excess subnucleus-specific cDNA generated for the microarray as template (see also [Table S2](#SD2){ref-type="supplementary-material"}). For gene expression studies on hindbrain cryosections, *Isl1* expression in near-adjacent sections was used to determine the approximate boundaries of the facial motor nucleus.

### Immunostaining {#S21}

Embryonic mouse heads were prepared and sectioned as described in *Retrograde tracing and axotomy* above. Cryosections were blocked for immunofluorescent staining (2% goat serum in phosphate buffered saline \[PBS\] supplemented with 0.1% Triton X-100 \[PBST\]) and incubated overnight at 4°C with the following primary antibodies diluted in blocking buffer: rabbit anti-ETV1 (RRID: AB_2617167) 1:4000, guinea pig anti-FOXP1 (RRID: AB_2665444) 1:1000, guinea pig anti-ISL1/2 (RRID: AB_2631974) 1:1000 (kind gifts of Tom Jessell), rabbit anti-FOXP1 (RRID: AB_732428) 1:1000 (Abcam), rabbit anti-GFP (ThermoFisher Cat\#A11122, RRID: AB_221569) 1:2000 (sections), 1:500 (whole mount), chick anti-GFP (ThermoFisher Cat\#A10262, RRID: AB_2534023) 1:1000, rabbit anti-cleaved Caspase-3 (Cell Signaling Technologies Cat\#9661S, RRID: AB_2341188) 1:1000, rabbit anti-Ankyrin G (Santa Cruz Cat\# sc-31776, RRID: AB_633908) 1:250, mouse anti-myosin, fast (Sigma Aldrich Cat\# M1570--200UL, RRID: AB_2147168) 1:500; rabbit anti-neurofilament (EMD Millipore Cat\# AB1987, RRID: AB_91201), 1:500. Slides were washed in PBST and incubated for two h at room temperature with Alexa Fluor 488-, 568- and 647-conjugated secondary antibodies diluted 1:1000 in blocking buffer. Alexa Fluor 594 alpha-bungarotoxin (Life Technologies) was included in some instances to label facial muscles in cross section. Slides were coverslipped in Fluoromount G (SouthernBiotech) and imaged on a LSM 5 Pascal confocal microscope (Zeiss). To examine the overlap of FMN subpopulation identity and gene expression, facial nerve branches and muscles of neonatal mice were labeled with retrograde tracers and hindbrains processed and cryosectioned as described above. Cryosections were air dried, imaged for the accumulation of fluorescent label, and processed for chromogenic ISH detection. Images documenting the retrograde fluorescent labeling were superimposed on corresponding ISH images in Photoshop and transparency of the fluorescent retrograde label image was adjusted to approximately 50%. Size and position of the fluorescent retrograde label images were aligned with the ISH images based on common, preserved sample contours and anatomic landmarks.

Whole-mount immunostaining of wild-type E11.5-E15.5 mouse heads was performed using the iDISCO method ([@R54]). Briefly, embryos and heads were fixed overnight in 4% paraformaldehyde, dehydrated through a methanol series, bleached overnight in 5% H~2~O~2~ in methanol, rehydrated through a methanol series, and washed in PBS with 2% Triton X-100. Samples were then permeabilized and blocked (two days each process) and incubated with primary antibody diluted in a solution of 2% Tween-20 and 0.01mg/ml heparin in PBS (PTwH) supplemented with 5% DMSO and 3% donkey serum for 7 days. Following one day of washes using PTwH, samples were placed in secondary antibody diluted in a solution of PTwH with 3% donkey serum for 7 days. Stained tissue was washed in PTwH, dehydrated through a methanol series, and incubated in a solution of dichloromethane and methanol. Samples were cleared in dibenzyl ether, mounted on coverslips, and imaged on a Zeiss LSM 700 series laser scanning confocal microscope using Zen Software (Carl Zeiss MicroImaging GmbH, Gottingen, Germany) and manipulated in three dimensions using Imaris software (Bitplane, Zurich, Switzerland).

### Examination of proximal axon orientation {#S22}

Facial motor subnuclei of wild-type *Thy1::YFP* mice were marked with retrograde Rh-Dx tracer as described above. Coronal facial motor nucleus cryosections (50 μm thick) were stained for Ankyrin G immunofluorescence. Quantitation was restricted to FMNs for which Ankyrin G labeling terminated unambiguously in a discrete neuron marked by dextran labeling and GFP expression. AIS directional vectors were determined, superimposed on a common origin in PowerPoint, and assigned to one of four bins corresponding to dorsal, lateral, ventral, and medial quadrants ([@R46]).

### FMN birth-dating {#S23}

Timed pregnant mice were treated with 5-ethynyl-2′-deoxyuridine (EdU, 50 mg/kg, approximately 200 μl of 5 mg/ml EdU in phosphate buffered saline \[PBS\]) ([@R57]) by interperitoneal injection. Embryos were harvested at E14.5 and fixed for cryosectioning as described above. Cryosections (20 μm) were stained with antibodies against ISL1 and either ETV1 or FOXP1 and corresponding Alexa Fluor secondary antibodies as described above. Following two washes with PBS, slides were permeabilized in PBS supplemented with 0.2% Triton X-100 for 30 min and then washed twice in PBS. For each slide, 215 μL of PBS was mixed with 10 μl of 0.1M CuSO~4~ and 0.5 μl of Alexa 555-azide while in a second tube 22.5 μL of water was mixed with 2.5 μl ascorbic acid (0.5 M). The two components were mixed by pipetting, applied to the slide and incubated for 30 min at room temperature with light protection. Slides were washed twice in PBS, incubated with 1.4 μM 4',6-diamidino-2-phenylindole (DAPI) to mark nuclei, washed twice in PBS, mounted, and imaged on a Zeiss confocal microscope. FMNs detected in individual optical sections were scored as EdU-positive if the Alexa-azide staining coincided with approximately 50% or more of the neuronal nucleus defined by ISL1 immunoreactivity.

### FMN quantification {#S24}

Hindbrain cryosections (25 μm) from E16.5 *Etv1* mutant and control littermates were stained for rabbit anti-ISL1 immunofluorescence and DAPI as above. Nuclei that co-stained for ISL1 and DAPI were counted in confocal stack images with IMAGEJ (NIH). The minimum sample size required to detect the possible loss of approximately 600 DL FMNs in the *Etv1* mutant mice was determined using 2 sample, 1-sided power analysis assuming 80% power and an error rate of 5% using the observed average FMN numbers and standard deviations.

### Analysis of OO FMN settling position {#S25}

OO FMNs were identified by retrograde Rh-Dex labeling of cut motor fibers supplying the nasal OO muscle in neonatal control and *Etv1* mutant mice. Coronal cryosections through the facial nucleus were imaged for ISL1 immunofluorescence and the distribution of Rh-Dex. To quantify the mediolateral distribution of labeled OO FMNs, the facial nucleus was divided along the mediolateral axis into four bins of equal width and the percentage of labeled FMNs occupying each bin in control and *Etv1* mutants was determined.

### Analysis of facial muscle innervation {#S26}

Heads were collected from control and *Etv1* mutant E16.5 embryos (both in a *Thy1::YFP* Line 16 background), skinned and stained with rabbit anti-GFP and mouse anti-fast myosin (MY32) antibodies as described ([@R32]). Briefly, embryonic heads were fixed and dehydrated as described above, incubated overnight in Dent's bleach (1 part H2O2, 2 parts Dent's fix) and in Dent's fix (1 part DMSO, 4 parts methanol). Samples were then incubated in primary antibodies diluted in blocking solution (5% goat serum, 20% DMSO in PBS) for 3 days at room temperature, followed by similarly diluted secondary antibodies. Samples were washed in PBS, dehydrated through a methanol series, cleared in 2:1 parts benzoic acid:benzyle benzoate (BABB), and mounted on a coverslip. Confocal Z series were collected with microscope settings that placed the anti-GFP signal from the Z/T branch dorsal to the eye at saturation. Maximum projections of the myosin immunostaining defined the region of interest (ROI) encompassing the NL muscle, and the maximum projection of the GFP immunostaining was uniformly contrast enhanced, made binary, and the GFP signal within the NL ROI was quantified using ImageJ image analysis software (NIH). To quantify OO and ML innervation, GFP immunofluorescence associated with cryosection (25 μm thick) muscle ROIs defined by diffuse Alexa 555-alpha bungarotoxin (A555-Btx) was quantified as described for whole mount NL preparations.

### Determination of Palpebral Closure Index {#S27}

Photographs of P19 control and *Etv1* mutant faces oriented in profile centered on the eyelid were collected and the ratio of the height and width of the palpebral fissure was determined using ImageJ and averaged across five photographs per animal.

### Analysis of facial muscle physiology {#S28}

Bipolar, single strand steel wire EMG electrodes were fabricated and implanted as described ([@R53]) into the belly of the nasolabialis (NL) and the dorsotemporal quadrant of the orbicularis oculi (OO) muscles of control and *Etv1* mutant mice at P18, a time point necessitated by the lethality of the homozygous *Etv1* mutation in the first 3--5 postnatal weeks ([@R2]). Mice were restrained but free range of motion was maintained for the head and mystacial pad. Only epochs recorded when whisking behavior was observed in the absence of locomotion or body movement were analyzed. Successful NL muscle implantation was defined by the detection of high frequency, rhythmic electromyographic (EMG) activity coincident with whisking behavior; successful OO implantation was defined by the detection of short duration, high amplitude activation coincident with blink behavior in response to noxious air puffs.

EMG signals were amplified (MA-102, Zoological Institute, University of Cologne) and recorded (1401, Cambridge Electronic Design) for offline analysis using Spike2 (CED, v.6.02) and Excel. Assays of EMG fidelity with muscle activation were initially checked against time-synched video capture (240 fps, Casio Exilim FC200) of whisking and eyelid blink behavior to eliminate artifacts, with recording of muscle-activated bursts subsequently identified manually. Behavior-related EMG activation was defined as greater than 3 SD above the average baseline value recorded 20--500 msec preceding EMG burst onset. Exploratory whisking behavior was defined as high-frequency, rhythmic EMG activation between 5--11 Hz lasting 1.9--5.9 s (n = 14 mice).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S29}
---------------------------------------

Averages and standard deviations were calculated using Excel; standard error was equal to (standard deviation of the average of n independent experiments/$\sqrt{n}$). Statistical significance was defined by p values \< 0.05 from an unpaired t test (<https://www.graphpad.com/quickcalcs/ttest1/?Format=SEM>). Power and sample size for FMN quantification were evaluated using 2 sample, 1-sided power analysis (<http://powerandsamplesize.com/Calculators/Compare-2-Means/2-Sample-1-Sided>).

DATA AND CODE AVAILABILITY {#S30}
--------------------------

The accession number for the E16.5 facial motor subnuclei microarray cel files reported in this paper is GEO: GSE134807.
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![Molecular Heterogeneity among Somatotopic Facial Motor Subnuclei\
(A) Schematic of facial-motor nucleus development in the embryonic mouse hindbrain. Facial motor neurons (FMN) emerge from the rhombomere 4 (r4) midline germinal zone (green oval) and migrate caudally and laterally (dotted lines) to form somatotopic subnuclei in ventral r6. Red dashed line marks the plane of section for (B) and (B′).\
(B and B′) *In situ* hybridization (ISH) for *Isl1* in a transverse-hindbrain section through the facial nucleus at E16.5. Dashed box denotes position of high-power image (B′). Dashed lines in (B′) outline approximate anatomic borders of the medial (M), intermediate (I), dorsolateral (DL), and lateral (L) facial motor subnuclei.\
(C) Schematic indicating the positions at which the posterior auricular (PA) and anterior auricular (AA), marginal mandibular (MM), zygomatic/temporal (Z/T), superior buccolabial (sBL) and inferior buccolabial (iBL) nerves were transected and marked with the retrograde rhodamine-dextran (Rh-Dex) tracer. Eyelid-closing orbicularis oculi (OO) and extrinsic whisking nasolabialis (NL) muscles are indicated. Dotted region represents the cervical (C) facial-nerve branch that was not included in the study\
(D--I) Coronal sections through P2 mouse hindbrains after retrograde Rh-Dx labeling of the PA (D), AA (E), MM (F), Z/T (G), sBL (H), and iBL (I) facial nerve branches as described in (C). Dotted line denotes facial nucleus border.\
(J) Schematic summary of the distribution of FMNs contributing to the indicated facial nerve branches.\
(K and L) Cresyl violet-stained coronal section through the E16.5 wild-type facial nucleus (dashed line) before (K) and after (L) laser-capture microdissection (LCM) to isolate M, I, DL, and L facial subnuclei.\
(M) Predicted subnucleus-specific enrichment of select markers identified in microarray screen. (Top) Histograms show genes for which a microarray probe showed approximately 40% or more total normalized expression enriched in a single subnucleus, color coded to represent the normalized expression in each of the subnuclei. (Bottom) Diagrams show predicted gene-expression patterns.\
Scale bars: 200 μm in (B) and (D)--(I) and 100 μm in (B') and (K).\
See also [Table S1](#SD3){ref-type="supplementary-material"} and [Figures S1](#SD1){ref-type="supplementary-material"} and [S6](#SD1){ref-type="supplementary-material"}.](nihms-1544149-f0002){#F1}

![Unique, Combinatorial Gene Expression Programs Define Facial Motor Subnuclei and Pools\
(A--F) ISH for facial subnucleus markers in coronal cryosections at E16.5 (A--D) and P3 (E and F). Dashed lines in (A)--(F) outline the approximate boundary of the facial nucleus.\
(A) Class 1A microarray hits defining distinct facial subnuclei.\
(B) Class 1B microarray hits marking subpopulations within a single subnucleus.\
(C) Class 2 microarray hits defining two subnuclei or subpopulations therein.\
(D) Class 3 microarray hits marking FMNs of three or more facial subnuclei.\
(E) Simultaneous injection of retrograde Alexa 555- and Alexa 647-conjugated cholera toxin B (A555CTB and A647CTB) labels into OO and NL muscles, respectively, marking distinct motor pools within the *Etv1*^*ON*^ DL facial-motor subnucleus. Representative images.\
(F) Single CTB injection followed by ISH identifies *Cntn3* as an OO motor pool marker, whereas *Sostdc1*, *ALCAM*, and *Gria3* define the NL pool. *Sostdc1*^*ON*^ (arrows) and *Sostdc1*^*OFF*^ (arrowheads) NL FMNs are indicated.\
(G) Specificity of motor pool markers in (F) represented as mean ± SE percentage of FMNs marked by retrograde muscle labeling expressing the indicated motor-pool markers. n = 3 mice per muscle injection, (\*p \< 0.05, \*\*p \< 0.005, \*\*\*p \< 0.0005, unpaired t test).\
(H) Summary of OO and NL motor-pool molecular identities.\
Scale bars: 100 μm in (A)--(D) and 200 μm (E) and (F).\
See also [Figures S1](#SD1){ref-type="supplementary-material"}, [S2](#SD1){ref-type="supplementary-material"}, and [S6](#SD1){ref-type="supplementary-material"}.](nihms-1544149-f0003){#F2}

![FMN Molecular Identity and Nerve-Branching Pattern Are Maintained in the Absence of Caudal Migration\
(A--C) Time course of *Isl1* (A), *FoxP1* (B), and *Etv1* (C) expression in the developing hindbrain. Whole mount ISH, hindbrain ventral views. Asterisks indicate the r4 FMN germinal zone; white-filled arrows mark the final FMN settling position at E11.5 and E12.5; black-filled arrows indicate *FoxP1*-expressing I (B) and *Etv1*-expressing DL (C) subnuclei at E13.5 and E15.5; open arrowheads in (A) and (C) mark a subpopulation of *Etv1*-expressing FMNs occupying M positions within the E15.5 facial subnucleus.\
(D--F) Immunofluorescence staining for FOXP1/ISLl (D), ETV1/ISL1 (E), and ETV1/FOXP1 (F) on coronal cryosections through r5/6 (E11.5 and E12.5) and r6 (E13.5 and E15.5). Dashed white lines outline the dorsal and ventral surfaces of the hindbrain; thick solid white lines in (D) and (E) outline DL and I facial motor subnuclei, respectively; thin gray lines in (F) outline the FMN migratory stream and nascent facial nucleus. Representative images, n = 3 embryos per time point.\
(G--L) ETV1 (G and J) and FOXP1 (H and K) expression in control (G and H) and *Cdk5*^−/−^(J and K) FMNs at E16.5. Coronal planes of section indicated in (I) and (L), n = 1 *Cdk5*^−/−^, n = 1 wild-type littermate control.\
Scale bars: 500 μm in (A)--(C) and 100 μm in (D)--(F), (G), (H), (J), and (K).\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1544149-f0004){#F3}

![FMN Transcriptional and Positional Identities Are Linked to Birth Date and Secondary Migration within the Developing Facial Nucleus\
(A--F) FMNs settle in the ventral hindbrain along a mediolateral developmental axis. Time course of EdU birthdate labeling (red) combined with ETV1 (green) and ISL1 (blue) immunofluorescence in (A)--(C), and ETV1 (green) and FOXP1 (blue) immunofluorescence in (D)--(F). EdU administration at E9.5 marks M FMNs, whereas administration at E11 and E12 mark progressively more lateral FMN populations. Arrows indicate EdU^+^/ISL1^ON^ in (A)--(C) and EdU^+^/ETV1^ON^ in (D)--(F) cells; triangles show EdU^+^/ETV1^ON^/ISL1^ON^ in (A)--(C) and EdU^+^/FOXP1^ON^ in (D)--(F) cells.\
(G) Percentage of EdU^+^/FOXP1^ON^ and EdU^+^/ETV1^ON^ detected at E14.5 after EdU delivery at the indicated time points represented as means ± SE. n = 3 embryos per injection time points E9.5 (290 ETV1^ON^ and 1,013 FOXP1^ON^ FMNs), E11 (639 ETV1^ON^ and 859 FOXP1^ON^ FMNs), and E12 (690 ETV1^ON^ and 876 FOXP1^ON^). Unpaired t test, \*p \< 0.05, \*\*p \< 0.005.\
(H--K) Ankyrin-G immunostaining (ANK-G, green) reveals variable axon initial segment (AIS) orientation among perinatal mouse facial subnuclei defined by retrograde Rh-Dx facial-nerve branch labeling (red); thin gray lines outline facial nucleus border. (H'--K') High-power images of boxed regions; Rh-Dx labeled FMNs (asterisks) and corresponding AISs (outlined by thick white lines) are indicated. n = 3 mice per nerve branch.\
(L) Radar plots indicating, for each subnucleus, the proportion of AISs assigned to the indicated directional quadrant bins (Q1--Q4); inset shows example diagram with an L FMN AIS (green) assigned to the Q1 bin. n = 3 mice each for each subnucleus, with 42 M, 65 I, 75 DL, and 80 L FMNs marked by retrograde labeling of the PA/AA, MM, Z/T, and BL nerve branches, respectively.\
(M) Model for facial subnucleus formation through secondary migration based on marker expression and AIS orientation vectors. Directional vectors for final steps of secondary migration through which FMNs coalesce into discrete subnuclei are indicated.\
Scale bars: 50 μm in (A)--(F) and 200 μm in (H)--(K).\
See also [Figure S6](#SD1){ref-type="supplementary-material"}.](nihms-1544149-f0005){#F4}

![Loss of DL Subnucleus FMNs Positional and Transcriptional Identities in *Etv1* Mutant Mice\
(A--D) Facial nucleus cytoarchitecture in E17.5 *Etv1*^*nlz/+*^ (A and C) and *Etv1*^*nlz/nlz*^ (B and D) embryos as defined by *Isl1* ISH (A and B) and ISL1 immunostaining, blue in (C) and (D). An anatomically distinct DL subnucleus is absent from *Etv1* mutant embryos, arrows in (B) and (D); and the β-gal reporter marking DL FMNs in *Etv1*^*nlz/+*^ embryos, green in (C), is absent from *Etv1-*mutant FMNs (D). The location of FOXP1^ON^ I FMNs (red in C and D) is unchanged in *Etv1* mutants. Green puncta, in (C) and (D), are non-specific background binding of the anti β-gal antibody.\
(E and F) Immunofluorescent detection of cleaved caspase-3 apoptosis marker (CASP3, green) in control (E) and *Etv1* mutant (F) ISL1^ON^ (red) FMNs at E14.5.\
(G) Ratio of CASP-3^ON^, ISL1^ON^ to CASP-3^OFF^, ISL1^ON^ FMNs detected in *Etv1*^*nlz/nlz*^ and control E14.5 embryos in (E) and (F) represented as means ± SE, n = 3 *Etv1* mutant (208 FMNs) and control (238 FMNs) littermate pairs (unpaired t test, p = 0.7639).\
(H and I) Retrograde labeling (green cells, white arrows) of DL FMNs in neonatal control (H) and *Etv1*^*nlz/nlz*^ (I) mice with Rh-Dx application to the transected Z/T nerve branch.\
(J) Similar numbers of DL FMNs are marked in neonatal control and *Etv1*^*nlz/nlz*^ mice, represented as ISL1^ON^ FMNs and Rh-Dx-labeled FMNs means ± standard error. n = 3 mice for each genotype: 139 *Etv1* mutant and 152 control DL FMNs (unpaired t test, p = 0.4769).\
(K) Rh-Dx-labeled OO FMNs assigned to one of four mediolateral positional bins. OO FMNs are more broadly distributed in *Etv1* mutant mice than they are in littermate controls, represented as the percentage of OO FMNs assigned to each bin ± SEM. n = 3 *Etv1*^*nlz/nlz*^ and control littermate pairs, 121 and 114 OO FMNs analyzed, respectively, from the two genotypes (unpaired t test, \*p \< 0.005, \*\*p \< 0.0005).\
(L--S) Expression of the motor neuron marker *Isl1* (L); the class 1 DL markers *Etv1* (M), *Cntn3* (N), and *Sostdc1* (O); class 2 DL markers *C1ql1* (P), and *Gria3* (Q); and the class 3 DL markers *Ldb2* and *Alcam* in control (upper panels) and *Etv1*^*nlz/nlz*^ (lower panels) facial nuclei at E16.5. Black arrowheads in (M)--(R) indicate DL motor-pool markers present in wild type and their absence from *Etv1* mutant, facial motor nuclei; arrows in (P)--(S) indicate FMN marker expression maintained in *Etv1* mutants. Open arrowheads in (S) mark *Alcam*^*ON*^ FMNs ectopically occupying the L subnucleus.\
Scale bars: 100 μm in (A--D) and (L--S); 50 μm in (E) and (F); and 200 μm in (H) and (I), n ≥ 3 mice for each gene.\
See also [Figures S3](#SD1){ref-type="supplementary-material"} and [S4](#SD1){ref-type="supplementary-material"}.](nihms-1544149-f0006){#F5}

![Attenuation of DL Facial Motor Subnucleus Target Muscle Innervation in *Etv1*-Mutant Mice\
(A) Time course of embryonic facial nerve development from E11.5 to E15.5. GFP immunostaining in embryonic *Isl1*^*MN*^*::GFP* mice. Arrows at E11.5 and E12.5 indicate the exit of the facial nerve from the pons. The ramification of the auricular (filled arrowheads at E11.5 and E12.5), zygomatic/temporal (filled arrowheads at E13.5 and E14.5), buccolabial (open arrowheads at E13.5 and E14.5), and marginal mandibular branches (arrows at E13.5 and E14.5) are indicated. Eye is marked with "e"; dorsal (D) and anterior (A) directions are indicated.\
(B--E) Z/T axon growth in wild-type (B and D) and *Etv1* mutant (C and E) embryos at E13.5 (B and C) and E15.5 (D and E). Z/T branch growth is unchanged in *Etv1* mutants at E13.5 (B and C), but attenuation of NL innervation is apparent by E15.5 (dotted lines in D and E). Arrows in (E) mark ectopic innervation of the NL by BL nerve-branch fibers.\
(F and H) GFP (green) and myosin (red) immunostaining on whole-mount NL muscles from control (F) and *Etv1*^−/−^(H) E16.5 *Thy1::YFP* embryos. NL innervation remains attenuated, arrow in (H) marks the ectopic invasion of the ventral NL by the BL nerve-branch fibers. No obvious change in Z/T facial nerve-branch caliber was observed in *Etv1-*mutant embryos, arrows in (B) and (C) and arrowheads in (F) and (H).\
(G and I) GFP immunofluorescence (green) and Alexa555 bungarotoxin (Btx, red) staining on coronal cross sections through nasal OO from control (G) and *Etv1-*mutant (I) *Thy1::YFP* mice at E16.5. OO innervation is reduced in *Etv1* mutants; dotted lines denote OO muscle, arrows label regions of OO innervation in the control muscle that is absent from the *Etv1* mutant.\
(J) NL and OO muscle innervation is reduced in *Etv1-*mutant mice, represented as the means of the ratio of muscle innervation detected in *Etv1*^*nlz/nlz*^ compared with littermate controls. Innervation of the maxillolabialis (ML) muscle supplied by the BL nerve branch is unchanged. n = 3 embryos per genotype (unpaired t test, \*p \< 0.05, \*\*p \< 0.005). Samples were cleared for imaging using iDISCO (A) or BABB (B--I); see [Method Details](#S17){ref-type="sec"}.\
(K and L) Summary of reduced innervation of the NL and OO muscles (shaded tan) by Z/T facial-nerve fibers (green) in *Etv1* mutants. Arrowhead in (L) indicates BL fibers from the L subnucleus mistargeted to the NL.\
Scale bars: 500 μm in (A)--(E), 250 μm in (F) and (H), and 500 μm in (G) and (I).\
See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1544149-f0007){#F6}

![Near Randomization of DL Facial Motor Axon Targeting in *Etv1* Mutant Mice\
(A--D) Facial motor nucleus cryosections from neonatal wild-type (A and B) and *Etv1* mutant (C and D) mice showing retrograde Rh-Dx labeling from NL and OO motor fibers (red) overlaid with *Alcam* expression (blue). Boxes denote positions of high-power images (A'--D'). Selectivity of *Alcam* expression in NL (A', arrows) and its exclusion from OO (B', arrowheads) FMNs is lost in *Etv1* mutants, with many *Alcam*^OFF^ FMNs innervating the NL (arrowheads in C') and *Alcam*^*ON*^ FMNs innervating the OO (arrows in D'). Arrow head in (A') marks a likely *Alcam*^*OFF*^ NL FMN.\
(E) Coincidence of *Alcam* NL pool-marker expression in OO or NL FMNs, as represented by the percentage (± SE) of FMNs marked by retrograde muscle labeling that express *Alcam*. The specificity of NL innervation by *Alcam*^ON^ FMNs in control mice is lost in *Etv1* mutants. FMNs marked by OO and NL retrograde labeling were scored for colocalization of *Alcam* in control and age-matched *Etv1*^*nlz/nlz*^ mice. Data represented as the percentage (± SE) of FMNs marked by retrograde label and *Alcam* expression, n = 3 mice per genotype, 52 NL and 47 OO FMNs from control mice and 98 NL and 47 OO FMNs from *Etv1-*mutant mice (unpaired t test, \*p \< 0.05, \*\*p \< 0.0005). Scale bar: 200 μm.\
(F--I) Eyelid behavior in control (F and G) and *Etv1-*mutant (H and I) mice at P21 before (F and H) and after (G and I) Z/T facial nerve-branch axotomy. OO axotomy partially rescued tonic eyelid closure in *Etv1* mutants, whereas the dimensions of the palpebral fissure remained unchanged in controls.\
(J) Quantitation of axotomy-induced changes in palpebral fissure dimensions. Values represented as PCI means ± SE, n = 4 mice per genotype (unpaired t test, \*p \< 0.001, \*\*p = 0.0001).\
(K--M) Electromyographic (EMG) recordings from the OO and NL muscles of control (K and L) and *Etv1-*mutant (M) mice at P20. OO muscle did not contract during exploratory whisking in control mice (K) but in *Etv1-*mutant mice, the OO was activated simultaneously and synchronously with the NL during bouts of exploratory whisking (M). n = 8 control, 6 mutant mice.\
(N) Diagram of changes in peripheral facial-motor circuitry leading to OO/NL synkinesis in *Etv1* mutants.\
See also [Figure S7](#SD1){ref-type="supplementary-material"}.](nihms-1544149-f0008){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                                                       SOURCE                          IDENTIFIER
  ------------------------------------------------------------------------------------------------------------------------- ------------------------------- -----------------------
  Antibodies                                                                                                                                                
  Rabbit anti-Etv1                                                                                                          Tom Jessell laboratory          AB_2617167
  Guinea pig anti-FoxP1                                                                                                     Tom Jessell laboratory          AB_2665444
  Guinea pig anti-Isl1/2                                                                                                    Tom Jessell laboratory          AB_2631974
  Rabbit anti-FoxP1                                                                                                         Abcam                           AB_732428
  Rabbit anti-GFP                                                                                                           ThermoFisher                    AB_221569
  Chicken anti-GFP                                                                                                          ThermoFisher                    AB_2534023
  Rabbit anti-cleaved Caspase-3                                                                                             Cell Signaling Technologies     AB_2341188
  Rabbit anti-Ankyrin G                                                                                                     Santa Cruz                      AB_633908
  Mouse anti-myosin, fast                                                                                                   Sigma Aldrich                   AB_2147168
  Chemicals, Peptides, and Recombinant Proteins                                                                                                             
  Dextran, Tetramethylrhodamine-conjguated, 10,000MW                                                                        ThermoFisher                    NA
  Alpha bungarotoxin                                                                                                        Life Technologies               NA
  Choleratoxin B subunit,Alexa-congugated                                                                                   ThermoFisher                    NA
  Deposited Data                                                                                                                                            
  .cel data for microarray analysis of E16.5 dorsolateral (DL1--3), intermediate (I1--3), lateral (L1--3), medial (M1--3)   Gene Expression Omnibus (GEO)   GSE134807
  Experimental Models: Organisms/Strains                                                                                                                    
  Etv1^nlsLacZ/+^ mice                                                                                                      [@R2]                           RRID:MGI:3621019
  B6.Cg-Tg(Thy1-YFP)16Jrs/J mice                                                                                            [@R16]                          RRID:IMSR_JAX:003709
  *B6;129-Cdk5*^*tm1Kul*^*/J* mice                                                                                          [@R50]                          RRID:IMSR_JAX:003536)
  Tg(Isl1-EGFP\*)1Slp/J mice                                                                                                [@R39]                          RRID:IMSR_JAX:017952
  Oligonucleotides                                                                                                                                          
  Primers for RNA riboprobe template amplification with PCR; See [Table S1](#SD3){ref-type="supplementary-material"}        NA                              NA
  Software and Algorithms                                                                                                                                   
  IMAGEJ                                                                                                                    NIH                             RRID:SCR_003070
  Spike2 (CED, v.6.02)                                                                                                      Cambridge Electronic Design     RRID:SCR_000903

###### Highlights

-   Developing somatotopic facial motor neurons are transcriptionally diverse

-   *Etv1* is required for dorsolateral facial-motor neuron migration and axon targeting

-   Axon mistargeting makes the eyelid muscle "whisk" in *Etv1* mutants
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